Abel Hall LLC Grows Stock Position in Oracle Corporation $ORCL

Abel Hall LLC boosted its stake in Oracle Corporation (NYSE:ORCL) by 16.3% in the second quarter, Holdings Channel reports. The fund owned 2,144 shares of the enterprise software provider’s stock after buying an additional 300 shares during the quarter. Abel Hall LLC’s holdings in Oracle were worth $469,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Reyes Financial Architecture Inc. boosted its holdings in Oracle by 7.2% in the 2nd quarter. Reyes Financial Architecture Inc. now owns 643 shares of the enterprise software provider’s stock worth $141,000 after acquiring an additional 43 shares during the period. Creative Capital Management Investments LLC boosted its holdings in Oracle by 5.7% in the 2nd quarter. Creative Capital Management Investments LLC now owns 798 shares of the enterprise software provider’s stock worth $174,000 after acquiring an additional 43 shares during the period. Davis Investment Partners LLC boosted its holdings in Oracle by 0.7% in the 2nd quarter. Davis Investment Partners LLC now owns 6,930 shares of the enterprise software provider’s stock worth $1,517,000 after acquiring an additional 46 shares during the period. Acropolis Investment Management LLC boosted its holdings in Oracle by 2.6% in the 2nd quarter. Acropolis Investment Management LLC now owns 1,850 shares of the enterprise software provider’s stock worth $404,000 after acquiring an additional 47 shares during the period. Finally, Sunpointe LLC boosted its holdings in Oracle by 0.9% in the 2nd quarter. Sunpointe LLC now owns 5,563 shares of the enterprise software provider’s stock worth $1,216,000 after acquiring an additional 48 shares during the period. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Insider Buying and Selling

In other Oracle news, Director Naomi O. Seligman sold 2,222 shares of the stock in a transaction on Friday, September 26th. The stock was sold at an average price of $288.91, for a total value of $641,958.02. Following the sale, the director directly owned 29,225 shares of the company’s stock, valued at $8,443,394.75. This trade represents a 7.07% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Michael D. Sicilia sold 33,845 shares of the stock in a transaction on Tuesday, September 23rd. The stock was sold at an average price of $321.16, for a total value of $10,869,660.20. Following the completion of the sale, the insider directly owned 132,656 shares in the company, valued at $42,603,800.96. This represents a 20.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 104,314 shares of company stock valued at $31,272,223 over the last three months. Corporate insiders own 40.90% of the company’s stock.

Oracle Stock Performance

ORCL stock opened at $284.46 on Wednesday. The company has a current ratio of 0.62, a quick ratio of 0.62 and a debt-to-equity ratio of 3.33. The firm has a market cap of $810.94 billion, a P/E ratio of 65.85, a P/E/G ratio of 3.14 and a beta of 1.53. Oracle Corporation has a 12-month low of $118.86 and a 12-month high of $345.72. The stock’s 50 day simple moving average is $264.10 and its 200 day simple moving average is $207.36.

Oracle (NYSE:ORCL) last posted its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.48 by ($0.01). The firm had revenue of $14.93 billion for the quarter, compared to analyst estimates of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The business’s revenue was up 12.2% on a year-over-year basis. During the same period in the prior year, the company posted $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, equities research analysts predict that Oracle Corporation will post 5 EPS for the current year.

Oracle Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Thursday, October 9th. Oracle’s dividend payout ratio is currently 46.30%.

Wall Street Analyst Weigh In

ORCL has been the subject of a number of analyst reports. Jefferies Financial Group upped their price target on Oracle from $270.00 to $360.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Raymond James Financial reaffirmed a “strong-buy” rating on shares of Oracle in a research report on Wednesday, June 18th. BNP Paribas set a $377.00 target price on Oracle in a research report on Wednesday, September 10th. BMO Capital Markets set a $345.00 target price on Oracle in a research report on Wednesday, September 10th. Finally, Wolfe Research upped their target price on Oracle from $300.00 to $400.00 and gave the company an “outperform” rating in a research report on Wednesday, September 10th. Two analysts have rated the stock with a Strong Buy rating, twenty-five have issued a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $304.71.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.